Risk factors predicting outcome in patients with pneumonia in Al-Ain, United Arab Emirates

Saudi Medical Journal

Volumn 27, Issue 7, 2006, Pages 1044-1048

  Al Muhairi, Shaikha S ^a   Zoubeidi, Taoufik A ^a   Ellis, Michael E ^a   Safa, Wassef F ^a   Joseph, Jose ^b  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CARBON DIOXIDE; CREATININE; NITROGEN; UREA;

ADOLESCENT; ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CARBON DIOXIDE TENSION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DATA ANALYSIS; DIABETES MELLITUS; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PNEUMONIA; PREDICTION; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SPUTUM CULTURE; SURVIVAL; SYSTOLIC BLOOD PRESSURE; UNITED ARAB EMIRATES; UREA NITROGEN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; UNITED ARAB EMIRATES;

EID: 33750373153     PISSN: 03795284     EISSN: 03795284     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med 1995; 333: 1618-1624.
2. de Castro FR, Torres A. Optimizing treatment outcomes in severe community-acquired pneumonia. Am J Respir Med 2003; 2: 39-54.
3. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-250.
4. Leroy O, Devos P, Guery B, Georges H, Vandenbussche C, Coffinier C, et al. Simplified prediction rule for prognosis of patients with severe community-acquired pneumonia in ICUs. Chest 1999; 116: 157-165.
5. Woodhead M. Community-acquired pneumonia in Europe: causative pathogens and resistance patterns. Eur Respir J Suppl 2002; 36: 20s-27s.
6. Woodhead M. Community-acquired pneumonia guidelines: much guidance, but not much evidence. Eur Respir J 2002; 20:1-3.
7. Kurashi NY, Al Hamdan A, Ibrahim EM, Al Idrissi HY, Al Bayari TH. Community acquired acute bacterial and atypical pneumonia in Saudi Arabia. Thorax 1992; 47: 115-118.
8. Efron B, Tibshirani RJ. An introduction to the bootstrap. New York: Chapman and Hall; 1993.
9. Almirall J, Bolibar I, Balanzo X, Gonzalez CA. Risk factors for community-acquired pneumonia in adults: a population-based case-control study. Eur Respir J 1999; 13: 349-355.
10. Fine MJ, Hough LJ, Medsger AR, Li YH, Ricci EM, Singer DE, et al. The hospital admission decision for patients with community-acquired pneumonia. Results from the pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med 1997; 157: 36-44.
11. Moine P, Vercken JB, Chevret S, Chastang C, Gajdos P. Severe community-acquired pneumonia. Etiology, epidemiology, and prognosis factors. French Study Group for Community-Acquired Pneumonia in the Intensive Care Unit. Chest 1994; 105: 1487-1495.
12. Ruiz M, Ewig S, Torres A, Arancibia F, Marco F, Mensa J, et al. Severe community-acquired pneumonia. Risk factors and follow-up epidemiology. Am J Respir Crit Care Med 1999; 160: 923-929.
13. Angus DC, Marrie TJ, Obrosky DS, Clermont G, Dremsizov TT, Coley C, et al. Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria. Am J Respir Crit Care Med 2002; 166: 717-723.
14. Lim WS, Lewis S, Macfarlane JT. Severity prediction rules in community acquired pneumonia: a validation study. Thorax 2000; 55: 219-223.
15. Neill AM, Martin IR, Weir R, Anderson R, Chereshsky A, Epton MJ, et al. Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax 1996; 51: 1010-1016.
16. Kamath A, Pasteur MC, Slade MG, Harrison BD. Recognising severe pneumonia with simple clinical and biochemical measurements. Clin Med 2003; 3: 54-56.
17. Farr BM, Sloman AJ, Fisch MJ. Predicting death in patients hospitalized for community-acquired pneumonia. Ann Intern Med 1991; 115: 428-436.
18. Ewig S, Schafer H, Torres A. Severity assessment in community-acquired pneumonia. Eur Respir J 2000; 16: 1193-1201.
19. Espana PP, Capelastegui A, Quintana JM, Soto A, Gorordo I, Garcia-Urbaneja M, et al. A prediction rule to identify allocation of inpatient care in community-acquired pneumonia. Eur Respir J 2003; 21: 695-701.
20. Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58: 377-382.
21. Smith RP, Lipworth BJ. C-reactive protein in simple community-acquired pneumonia. Chest 1995; 107: 1028-1031.
22. Masia M, Gutierrez F, Llorca B, Navarro JC, Mirete C, Padilla S, et al. Serum concentrations of lipopolysaccharide-binding protein as a biochemical marker to differentiate microbial etiology in patients with community-acquired pneumonia. Clin Chem 2004; 50: 1661-1664.
23. Mirete C, Gutierrez F, Masia M, Ramos JM, Hernandez I, Soldan B. [Usefulness of acute-phase proteins in community-acquired pneumonia]. Med Clin (Barc) 2004; 122: 245-247.
24. Zweigner J, Gramm HJ, Singer OC, Wegscheider K, Schumann RR. High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes. Blood 2001; 98: 3800-3808.
25. Medzhitov R, Janeway C, Jr. Innate immunity. N Engl J Med 2000; 343: 338-344.
26. Light RW, Girard WM, Jenkinson SG, George RB. Parapneumonic effusions. Am J Med 1980; 69: 507-512.
27. Joseph J, Badrinath P, Basran GS, Sahn SA. Is the pleural fluid transudate or exudate? A revisit of the diagnostic criteria. Thorax 2001; 56: 867-870.